Dansk Pharmaceuticals India Private Limited
Pharmaceutical company incorporated in 2020 with registered office in Haryana.
2020 | Faridabad, Haryana (India) | Active
Dansk Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.50 M
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.25 M
- Revenue Growth 2.85%
- Profit Growth -196.20%
- Ebitda -216.74%
- Net Worth -577.29%
- Total Assets 249.15%
About Dansk Pharmaceuticals India
Dansk Pharmaceuticals India Private Limited (DPIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 June 2020 (Four years and nine months 2 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹5.25 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bhagat Singh, Kuldeep Sangwan, Sunil Kumar, and Two other members serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230HR2020PTC086501
- Company No.
086501
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2020
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Dansk Pharmaceuticals India?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagat Singh  | Director | 15-May-2022 | Current |
| Kuldeep Sangwan | Director | 02-Jun-2020 | Current |
| Sunil Kumar | Director | 02-Jun-2020 | Current |
| Harinder Singh | Director | 01-Feb-2021 | Current |
| Renu Kumar | Director | 08-Oct-2024 | Current |
Financial Performance of Dansk Pharmaceuticals India.
Dansk Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.85% increase. The company also saw a substantial fall in profitability, with a 196.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 577.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dansk Pharmaceuticals India?
In 2022, Dansk Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Auriga Enterprises Llp
Bhagat Singh is a mutual person
- Lohagarh Organics Private Limited
Bhagat Singh is a mutual person
- Suzanna Jewels Private Limited
Bhagat Singh is a mutual person
- Lohagarh Kings Land Private Limited
Bhagat Singh is a mutual person
- Lohagarh Corbet Resort Private Limited
Bhagat Singh is a mutual person
- Meta Technology Solutions Private Limited
Bhagat Singh is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹5.25 M
Charges Breakdown by Lending Institutions
- Others : 0.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Others | ₹5.25 M | Satisfied |
How Many Employees Work at Dansk Pharmaceuticals India?
Dansk Pharmaceuticals India has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dansk Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dansk Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Dansk Pharmaceuticals India
Recent activity within the organization
- Director Appointment
Renu Kumar was appointed as a Director was appointed as a Director on 08 Oct 2024 & has been associated with this company since 4 months 27 days .
- Annual General Meeting
Dansk Pharmaceuticals India Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.
- Balance Sheet
Dansk Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge registered on 25 Mar 2022 via Charge ID 100553451 with Others was fully satisfied on 22 Jan 2024.
- Director Appointment
Bhagat Singh was appointed as a Director was appointed as a Director on 15 May 2022 & has been associated with this company since 2 years 9 months .
- Charges
A charge with Others amounted to Rs. 5.25 M with Charge ID 100553451 was registered on 25 Mar 2022.
Frequently asked questions
What is the Incorporation or founding date of Dansk Pharmaceuticals India Private Limited?
Dansk Pharmaceuticals India Private Limited was incorporated on 02 Jun 2020.
What is authorized share capital and paid-up capital of Dansk Pharmaceuticals India Private Limited?
The authorized share capital of Dansk Pharmaceuticals India Private Limited is ₹ 5.00 M and paid-up capital is ₹ 1.50 M.
Who are the current board members & directors of Dansk Pharmaceuticals India Private Limited?
Currently 5 directors are associated with Dansk Pharmaceuticals India Private Limited.
- Bhagat Singh
- Kuldeep Sangwan
- Sunil Kumar
- Harinder Singh
- Renu Kumar
What is the registered address of Dansk Pharmaceuticals India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Dansk Pharmaceuticals India Private Limited is House No. 2469/D Sector-64 India, Faridabad, Haryana, 121004.
What is the corporate identification number (CIN) and company number of Dansk Pharmaceuticals India Private Limited?
The corporate identification number (CIN) of Dansk Pharmaceuticals India Private Limited is U24230HR2020PTC086501 and the company number is 086501 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Dansk Pharmaceuticals India Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Dansk Pharmaceuticals India Private Limited has risen by 2.85%.
What change has been observed in the net worth of Dansk Pharmaceuticals India Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Dansk Pharmaceuticals India Private Limited has experienced an downturn of -577.29%.
When was the last Balance Sheet of Dansk Pharmaceuticals India Private Limited filed with the ROC?
The most recent Balance Sheet for Dansk Pharmaceuticals India Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Urmila PandeyDirectorGG
Gautam GuptaDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India